ND

Nazneen Dilkhush Tamboli

Active Director Director DIN 09333748
DIN 09333748 First appointment Sep 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Nazneen Dilkhush Tamboli

Data last updated:

Nazneen Dilkhush Tamboli is a Director at Bhaskaramrut Ayurved Private Limited (since 2021). The company operates in Healthcare.

DIN 09333748
Primary Designation Director
Industry Healthcare
First Appointment 25 Sep 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bhaskaramrut Ayurved Private Limited U24100PN2021PTC204589
Director25 Sep 20212021Active

Board colleagues of Nazneen Dilkhush Tamboli

NameDINCompanyDesignation
Dilkhush Makabul Tamboli09333747Bhaskaramrut Ayurved Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bhaskaramrut Ayurved Private Limited
Premium access

Shareholding and investment profile for Nazneen Dilkhush Tamboli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nazneen Dilkhush Tamboli

Nazneen Dilkhush Tamboli currently holds 1 directorship: Bhaskaramrut Ayurved Private Limited (Director, since 25 Sep 2021).

Nazneen Dilkhush Tamboli was first appointed on 25 Sep 2021 as Director at Bhaskaramrut Ayurved Private Limited.

The current boards of Nazneen Dilkhush Tamboli's companies include Dilkhush Makabul Tamboli (Bhaskaramrut Ayurved Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available